Replies to post #21729 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

I just discussed it the other day mopar...the ones who were in the mix at the end of calendar year 2013 on the heels of FocalinXR approval news and throughout the 1st few months of 2014 were all expecting the remaining FocalinXR strengths to be commercialized in May along with several more IPCI ANDA approvals...but then as we all know the FDA came along and slammed the door shut for 2 and a half years on any further ANDA approvals and the remaining Focalin strengths.

So big money said see ya later when the Focalin disappointment arrived and sure enough Dr Odidi had to do 2 small market raises over the past 2.5 years...so when big money is once again satisfied that IPCI's back on track...which could/should occur on a lucrative Rexista partnership announcement...we should all once again see the institutional types jumping back in here.

Will I be right...who knows...but the big boys tend to reward company's embarking on eras of impactful revenue generating growth...which is the gamble we take on all stocks we feel will see a dramatic increase in the valuation metrics that get applied depending on how well they execute.